According to Illumina's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 7.03314. At the end of 2022 the company had a P/S ratio of 6.39.
Year | P/S ratio | Change |
---|---|---|
2022 | 6.39 | -51.39% |
2021 | 13.1 | -21.23% |
2020 | 16.7 | 21.17% |
2019 | 13.8 | 4.02% |
2018 | 13.2 | 14.11% |
2017 | 11.6 | 47.86% |
2016 | 7.84 | -38.05% |
2015 | 12.7 | -11.12% |
2014 | 14.2 | 43.3% |
2013 | 9.94 | 65.67% |
2012 | 6.00 | 71.07% |
2011 | 3.51 | -60.03% |
2010 | 8.77 | 52.33% |
2009 | 5.76 | 2.43% |
2008 | 5.62 | -37.17% |
2007 | 8.95 | -10.32% |
2006 | 9.98 | 25.97% |
2005 | 7.92 | 10.88% |
2004 | 7.14 | -13.61% |
2003 | 8.27 | -24.19% |
2002 | 10.9 | -92.85% |
2001 | 152 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
![]() Thermo Fisher Scientific TMO | 5.01 | -28.75% | ๐บ๐ธ USA |
![]() Agilent Technologies A | 6.56 | -6.72% | ๐บ๐ธ USA |
![]() Quest Diagnostics
DGX | 1.61 | -77.07% | ๐บ๐ธ USA |
![]() Danaher DHR | 6.08 | -13.54% | ๐บ๐ธ USA |
![]() PerkinElmer
PKI | 3.74 | -46.78% | ๐บ๐ธ USA |
![]() Translate Bio
TBIO | N/A | N/A | ๐บ๐ธ USA |
![]() Pacific Biosciences
PACB | 18.3 | 159.83% | ๐บ๐ธ USA |
![]() Luminex LMNX | N/A | N/A | ๐บ๐ธ USA |